Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting 2024
November 18, 2024 18:00 ET | Source: Pliant Therapeutics, Inc. INTEGRIS-PSC featured…
TrueBinding Receives FDA IND Go Ahead for Parkinsons Phase 2A Clinical Trial
November 18, 2024 17:35 ET | Source: TrueBinding Inc. FOSTER CITY, Calif.,…
dentalcorp Announces $100 Million Bought Deal Treasury Offering and Secondary Offering of Subordinate Voting Shares
November 18, 2024 17:10 ET | Source: Dentalcorp Holdings Ltd. Not for…
REVISED – Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter
This revised news release replaces the one issued on November 14, 2024,…
SurgiBox Announces Strategic Partnership with Accord International to Expand into Japanese Market
TOKYO, Nov. 17, 2024 (GLOBE NEWSWIRE) -- SurgiBox Inc., a leader in…
KFSHRC Introduces Pioneering Virtual Pathology Services in Madinah
RIYADH, Saudi Arabia, Nov. 17, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist…
Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024
SAN FRANCISCO, Nov. 17, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq:…
Boehringer Ingelheim Commits to Veeva Vault CRM
Top biopharma company selects the next generation of CRM for life sciences as…
Foundation for Sarcoidosis Research (FSR) receives confirmation from the Department of Labor (DOL) ensuring patient access to FMLA for participation in clinical trials
CHICAGO, Nov. 16, 2024 (GLOBE NEWSWIRE) -- In August of 2023, the…
Anthos Therapeutics Shares New Analysis from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Substantially Reduced Bleeding in Patients on Antiplatelet Therapy Compared to Rivaroxaban
November 16, 2024 16:38 ET | Source: Anthos Therapeutics Data presented at…
